I read the research by Christina Kronberger et al. entitled "Exercise capacity assessed
with the one-minute sit-to-stand test (1-min STST) and echocardiographic findings
in patients with heart failure with preserved ejection fraction (HFpEF)" with great
enthusiasm. It was fortunate to read this work, and the author's efforts are to be
applauded.
1
We concur with the conclusion that the 1-min STST may have clinical value for clinicians
in decision-making regarding follow-up visits and optimizing medical care. Due to
the ease of use of the 1-min STST in an outpatient context, we concur with this result.
However, we are compelled to mention more points that would enhance the quality of
this text and expand previous information.- Kronberger C.
- Mousavi R.A.
- Öztürk B.
- et al.
Exercise capacity assessed with the one-minute sit-to-stand test (1-min STST) and
echocardiographic findings in patients with heart failure with preserved ejection
fraction (HFpEF).
Heart Lung. 2022; 55 (Sep-OctEpub 2022 May 11. PMID:35567840): 134-139https://doi.org/10.1016/j.hrtlng.2022.05.001
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart & Lung: The Journal of Cardiopulmonary and Acute CareAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Exercise capacity assessed with the one-minute sit-to-stand test (1-min STST) and echocardiographic findings in patients with heart failure with preserved ejection fraction (HFpEF).Heart Lung. 2022; 55 (Sep-OctEpub 2022 May 11. PMID:35567840): 134-139https://doi.org/10.1016/j.hrtlng.2022.05.001
- The 1-min sit-to-stand test in cystic fibrosis - Insights into cardiorespiratory responses.J Cyst Fibros. 2017; 16 (NovEpub 2017 Feb 7. PMID:28188010): 744-751https://doi.org/10.1016/j.jcf.2017.01.012
- Relation of microvascular dysfunction and exercise tolerance in patients with heart failure with preserved ejection fraction.Echocardiography. 2020; 37 (AugEpub 2020 Jul 26. PMID:32713077): 1192-1198https://doi.org/10.1111/echo.14799
- Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction: a report from the i-preserve trial (irbesartan in heart failure with preserved ejection fraction).Circulation. 2017; 135 (Feb 21Epub 2017 Jan 4. PMID:28052977): 724-735https://doi.org/10.1161/CIRCULATIONAHA.116.024593
- Echocardiographic estimation of left ventricular and pulmonary pressures in patients with heart failure and preserved ejection fraction: a study utilizing simultaneous echocardiography and invasive measurements.Eur J Heart Fail. 2017; 19 (DecEpub 2017 Oct 6. PMID:28984057): 1651-1660https://doi.org/10.1002/ejhf.957
Article info
Publication history
Published online: January 10, 2023
Accepted:
December 27,
2022
Received:
December 24,
2022
Publication stage
In Press Corrected ProofIdentification
Copyright
Published by Elsevier Inc.
